ArticleAntimicrobial agents and chemotherapy2018

Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical Modeling.

Cornelia B Landersdorfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.